TGFB1 and neoplasm: The higher expression of CD39 on CAR T cells in the spleen compared to those in the tumour likely reflects the more active immune environment of the spleen, while the tumour microenvironment's inhibitory signals, such as TGF‐β, hypoxia, and regulatory cells, may suppress CAR T cell activation and result in lower CD39 expression.33, 34